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Cardiac membrane fatty acid composition modulates myocardial oxygen 
consumption and postischemic recovery of contractile function 
Abstract 
Background— Regular fish consumption is associated with low cardiovascular disease morbidity and 
mortality. Fish oils modify cardiac membrane phospholipid fatty acid composition with potent 
antiarrhythmic effects. We tested the effects of dietary fish oil on ventricular hemodynamics and 
myocardial oxygen consumption (MVO2). Methods and Results— Male Wistar rats were fed for 16 weeks 
on a reference diet rich in n-6 polyunsaturated fatty acids (PUFA), a diet rich in saturated animal fat (SAT), 
or a diet rich in n-3 PUFA from fish oil. Isolated working hearts were perfused with porcine erythrocytes 
(40% hematocrit) at 75 mm Hg afterload with variable preload (5 to 20 mm Hg) or with low coronary flow 
ischemia with maintained afterload, preload, and heart rate, then reperfused. MVO2 was low and coronary 
perfusion reserve high in n-3 PUFA hearts, and cardiac output increased with workload. The n-3 PUFA 
reduced ischemic markers—acidosis, K+, lactate, and creatine kinase—and increased contractile recovery 
during reperfusion. SAT hearts had high MVO2, low coronary perfusion reserve, and poor contractile 
function and recovery. Dietary differences in MVO2 were abolished by KCl arrest (basal metabolism) or 
ruthenium red (3.4 μmol/L) but not by ryanodine (1 nmol/L). Fish oil or ryanodine, but not ruthenium red, 
prevented ventricular fibrillation in reperfusion. Conclusions— Dietary fish oil directly influenced heart 
function and improved cardiac responses to ischemia and reperfusion. The n-3 PUFA reduced oxygen 
consumption at any given work output and increased postischemic recovery. Thus, direct effects on 
myocardial function may contribute to the altered cardiovascular disease profile associated with fish 
consumption. 
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Cardiac Membrane Fatty Acid Composition Modulates
Myocardial Oxygen Consumption and Postischemic
Recovery of Contractile Function
Salvatore Pepe, PhD; Peter L. McLennan, PhD
Background—Regular fish consumption is associated with low cardiovascular disease morbidity and mortality. Fish oils
modify cardiac membrane phospholipid fatty acid composition with potent antiarrhythmic effects. We tested the effects
of dietary fish oil on ventricular hemodynamics and myocardial oxygen consumption (MVO2).
Methods and Results—Male Wistar rats were fed for 16 weeks on a reference diet rich in n-6 polyunsaturated fatty acids
(PUFA), a diet rich in saturated animal fat (SAT), or a diet rich in n-3 PUFA from fish oil. Isolated working hearts were
perfused with porcine erythrocytes (40% hematocrit) at 75 mm Hg afterload with variable preload (5 to 20 mm Hg) or
with low coronary flow ischemia with maintained afterload, preload, and heart rate, then reperfused. MVO2 was low and
coronary perfusion reserve high in n-3 PUFA hearts, and cardiac output increased with workload. The n-3 PUFA
reduced ischemic markers—acidosis, K, lactate, and creatine kinase—and increased contractile recovery during
reperfusion. SAT hearts had high MVO2, low coronary perfusion reserve, and poor contractile function and recovery.
Dietary differences in MVO2 were abolished by KCl arrest (basal metabolism) or ruthenium red (3.4 mol/L) but not
by ryanodine (1 nmol/L). Fish oil or ryanodine, but not ruthenium red, prevented ventricular fibrillation in reperfusion.
Conclusions—Dietary fish oil directly influenced heart function and improved cardiac responses to ischemia and
reperfusion. The n-3 PUFA reduced oxygen consumption at any given work output and increased postischemic
recovery. Thus, direct effects on myocardial function may contribute to the altered cardiovascular disease profile
associated with fish consumption. (Circulation. 2002;105:2303-2308.)
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Epidemiology and human intervention trials consistentlyshow inverse associations between dietary fish or fish oil
intake and mortality from heart disease.1–5 Because of the
importance of ischemic coronary artery disease in myocardial
infarction, sudden arrhythmic death, and heart failure, re-
search has largely focused on the influence of dietary fats on
blood pressure, plasma lipids, atherosclerosis, and
thrombosis.6–8
Animal studies demonstrate that dietary fats not only
modulate platelet and vascular function but also determine
the fatty acid composition of myocardial cell membranes.
Fish oils are rich sources of the long-chain 3 (n-3) polyun-
saturated fatty acids (PUFA) eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA). Eating fish oil leads to
high incorporation of DHA into myocardial membrane phos-
pholipid.9–14 Hearts with high DHA content have very low in
vivo and in vitro vulnerability to arrhythmia, which is
reflected in a low incidence of ventricular fibrillation induced
by ischemia, reperfusion, programmed electrical stimulation,
or other stimuli.10–14 This cannot be attributed to reduced
coronary atherosclerosis.15
Human intervention trials in postinfarction patients dem-
onstrate reduced mortality with regular intake of fish or fish
oil, without changes in blood pressure, blood lipids, or new
cardiac events.2,5 The Gruppo Italiano per lo Studio della
Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione
Trial,5 with 11 000 postinfarction subjects, found that fish
oil intake reduced the risk of both sudden and nonsudden
death. These reports support the animal data that indicate that
fish oil may prevent fatal arrhythmias, and they raise the
possibility that further direct effects on heart function may
contribute to the cardioprotective effects of n-3 fatty acids. In
support of this premise, fish oil feeding increases left ven-
tricular end-diastolic volume and ejection fraction in nonhu-
man primates and reduces rate pressure product, which may
be indicative of low myocardial oxygen consumption
(MVO2).16
We tested the hypothesis that n-3 PUFA incorporation into
myocardial membranes has direct effects on heart function,
particularly after ischemia, additional to previously reported
effects on arrhythmia, thrombosis, and vascular function. We
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used the erythrocyte-perfused isolated working heart, which
provides optimal oxygen delivery and permits assessment of
hemodynamic function and metabolism under controlled
physiologically relevant conditions.10,17
Methods
Animals and Diets
Four-month-old male Wistar rats (University of Adelaide, Adelaide,
Australia) were fed a fish oil (n-3 PUFA)–supplemented diet, a
saturated fat (SAT)-supplemented diet, or a reference diet (REF) rich
in n-6 PUFA for 16 weeks (n55 per diet). The REF diet was
commercially available, unrefined rat pellets (Milling Industries).
The SAT and n-3 PUFA diets were prepared as previously reported10
by adding sheep peri-renal fat or fish oil to the dry mix components
of the unrefined pellets. The fatty acid profile of each diet was
published previously.10 In brief, the n-3 PUFA diet contained 25%
saturated fatty acids and 45% PUFA (39% n-3 PUFA as EPA [20:5]
and DHA [22:6]), the SAT diet contained 55% saturated fat and 10%
PUFA (7% n-6 PUFA), and the REF diet contained 29% saturated fat
and 46% PUFA (34% n-6 PUFA). All diets were consumed
iso-energetically, delivering a similar total fat intake to all groups.10
Experiments were conducted according to the National Health and
Medical Research Council Australia Guidelines for the Use of
Experimental Animals.
Perfusion Protocol
At least 1 rat was used from each dietary group each experimental
day, and was fasted overnight. The experimenter was blind to the diet
of each rat. Animals were killed by cervical dislocation, and hearts
were removed and prepared for working heart perfusion with porcine
erythrocyte buffer (40% hematocrit).17 Briefly, after 10-minute
equilibration in Langendorff mode, hearts were switched to working
heart mode (preload, 10 mm Hg; afterload, 75 mm Hg; coronary
perfusion pressure, 75 mm Hg; paced heart rate, 300 bpm). Arterial
and venous blood gas partial pressures and pH were measured every
5 minutes. MVO2 was derived from arteriovenous oxygen differ-
ences per unit coronary flow, and external work was derived from
cardiac output (CO) and developed pressure.17
In separate experiments, we performed the following: (1) preload
was changed over the range 5 to 20 mm Hg by altering ventricular
filling pressure. (2) Global ischemia was induced by lowering the
coronary pressure to 35 mm Hg for 15 minutes while maintaining
afterload at 75 mm Hg and pacing throughout.23 Reperfusion was
initiated by restoring coronary perfusion pressure to 75 mm Hg. (3)
Basal MVO2 was determined in control and reperfused hearts
arrested in diastole by perfusion with 30 mmol/L KCl. Hearts were
continuously perfused with (1) the direct-acting vasodilator hydral-
azine (1 mmol/L), (2) the selective inhibitor of mitochondrial Ca
uptake ruthenium red (3.4 mol/L), or (3) the inhibitor of sarcoplas-
mic reticulum Ca release ryanodine (1 nmol/L). At completion,
hearts were blotted dry and weighed. A segment of ventricle was
retained for dry weight estimation, and the remainder was frozen in
liquid nitrogen and stored at 60°C.
Coronary Creatine Kinase, Lactate, and
Potassium Analysis
Creatine kinase (units per liter per minute) was measured spectro-
photometrically (340 nm, 37°C) using creatine kinase N-acetyl-L-
cysteine reagent (Behring). Lactate (millimoles per liter per minute)
was analyzed (340 nm, 37°C) by Cobass Bio (Hoffman-La Roche).
Creatine kinase and lactate release were adjusted for coronary flow
and expressed per gram ventricle (dry weight). Extracellular K
concentration (mmol/L) was measured by flame photometry.
Statistical Analysis
CO, external work, coronary flow, oxygen extraction, MVO2, and
metabolites were expressed per gram ventricle dry weight.17 Results
were expressed as meanSD. The effect of diet was tested by 1-way
ANOVA with Scheffe’s post-hoc F test for multiple comparisons of
individual means. Effects of ischemia/reperfusion and altered pre-
load were tested by repeated-measures ANOVA. The incidence of
ventricular fibrillation in reperfusion was compared using the 2 test.
Values in text sharing the same symbol were not significantly
different from other dietary groups. The level of significance was
considered at P0.05.
Results
Normoxic Function
Figures 1 and 2 (n55 per diet) summarize the hemodynamic
function of all hearts at equilibration, before subsequent
diversion to individual experiments (6 separate experiments
with individual groups of n5 to 10). There were no
differences between dietary groups in cardiac output (REF,
18214; SAT, 18315; n-3 PUFA, 18815 mL · min1 ·
g1) or external work (Figure 1A). SAT hearts had signifi-
cantly higher coronary flow, percent oxygen extraction (Fig-
ure 2A and 2B), and MVO2 (Figure 1B). Although coronary
flow was similar in n-3 PUFA and n-6 PUFA-rich REF, the
percent oxygen extraction and MVO2 were significantly
lower in n-3 PUFA hearts (Figures 2B and 1B). Body weights
(REF, 50410; SAT, 5255; n-3 PUFA, 5139 g), and
ventricle dry weights (REF, 0.250.01; SAT, 0.250.01; n-3
PUFA, 0.270.01 g) were not different.
Frank-Starling Relationship
The maximum CO (REF, 2107; SAT, 2013; n-3 PUFA,
27218 mL · min1 · g1) was significantly higher in n-3
PUFA hearts. In the REF and SAT hearts, CO was not
Figure 1. Effects of dietary lipids on cardiac external work (A), MVO2 (B), and efficiency of oxygen use (C) during control perfusion of
isolated working hearts. Values are meanSD; n55 per group; *P0.05 vs REF, ANOVA.
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sustained at high preload. The same pattern was seen in
external work (Figure 3A). Coronary flow was significantly
higher in SAT hearts at low (5 mm Hg) preload (REF, 303;
SAT, *871; n-3 PUFA, †212 mL · min1 · g1), whereas
the percent oxygen extraction was significantly lower in the
n-3 PUFA hearts (REF, 281%; SAT, 312%; n-3 PUFA,
181%). Coronary flow increased with preload in n-3 PUFA
and REF hearts only (maximum REF, 583; SAT, *904;
n-3 PUFA, †442 mL · min1 · g1). The percent oxygen
extraction increased with preload, but in the n-3 PUFA hearts,
this was only seen at the highest preload (max extraction:
SAT, 574%; REF, 391%; n-3 PUFA, 402%). MVO2
increased with preload in all groups, especially at the higher
filling pressures (Figure 3B) and was significantly greater in
SAT and less in n-3 PUFA at all preloads. The efficiency of
oxygen conversion into external work increased with preload
as external work increased but declined at the high filling
pressures as external work stabilized or declined (Figure 3C).
Efficiency was significantly higher in n-3 PUFA and lower in
SAT hearts at all preloads. Lactate washout into the coronary
perfusate increased with preload and was significantly higher
in SAT and lower in n-3 PUFA hearts (at 20 mm Hg preload:
REF, 23010; SAT, *2955; n-3 PUFA, †12512 mol ·
min1 · g1, n10).
Ventricular Function and MVO2 in Ischemia
and Reperfusion
Coronary flow decreased during ischemia (Figure 4A), barely
exceeded by CO (Figure 4B). After reperfusion, CO returned
to 83% of preischemic output in n-3 PUFA, 73% in REF, and
62% in SAT hearts (Figure 4B). Myocardial external work
decreased during ischemia in all groups (Figure 5A), and
recovery of external work after reperfusion was lowest in
SAT and highest in n-3 PUFA hearts.
Despite reduced work, MVO2 was not diminished in
reperfusion. Reperfused SAT hearts exhibited the highest,
whereas n-3 PUFA hearts had the lowest MVO2 (Figure 5B).
Figure 2. Effects of dietary lipids on coronary flow (A) and per-
cent coronary oxygen extraction (B) during control working heart
perfusion. Values are meanSD; n55 per group; *P0.05 vs
REF, ANOVA.
Figure 3. Effects of dietary lipids on cardiac external work (A), MVO2 (B), and efficiency of cardiac oxygen use (C) during changes in
ventricular preload (filling pressure) in isolated working heart: REF diet (‘), SAT diet (), and n-3 PUFA diet (). Values are meanSD;
n10 per group; *P0.05 vs REF, ANOVA.
Figure 4. Effects of dietary lipids on coronary flow (A), cardiac
output (B) in acute (15-minute) global low-flow ischemia and
reperfusion of isolated working heart: REF (open bars), SAT
(cross-hatched), and n-3 PUFA diet (filled bars). Values are
meanSD; n10 per group. *P0.05 vs REF, ANOVA; #P0.05
vs control, ANOVA.
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This resulted in lower energy utilization efficiency in SAT
hearts (ratio of work output energy/energy input from
MVO2), whereas n-3 PUFA hearts had significantly higher
postischemic energy efficiency than did n-6 PUFA–rich REF
hearts (Figure 5C).
Coronary venous pH fell during ischemia, (REF,
7.140.01; SAT, *7.030.02; n-3 PUFA, †7.200.01) and
K concentration increased (REF, 7.820.27; SAT,
8.630.42; n-3 PUFA, 5.360.23 mmol/L). These effects
were least pronounced in n-3 PUFA hearts, and the acidosis
was greatest in SAT hearts. The coronary venous washout of
lactate (REF, 21020; SAT, *30040; n-3 PUFA, †14030
mol · min1 · g1) and creatine kinase (REF, 12.10.5;
SAT, *17.44.4; n-3 PUFA, †1.30.1 IU · min1 · g1) was
significantly lower in n-3 PUFA hearts.
Ischemia at High Preload
During reperfusion at 20 mm Hg preload, oxygen extraction
(REF, 62.23.2%; SAT, 83.83.2%; n-3 PUFA,
58.11.5%) increased in all hearts, whereas MVO2 was
significantly increased in REF (26%) and SAT (24%) hearts
but not in n-3 PUFA hearts (11%) (n10 per diet (Control:
REF, 3.990.23; SAT, *7.540.53; n-3 PUFA, †2.960.17
mL · min1 · g1. Reperfusion: REF, 5.040.42; SAT,
*9.380.76; n-3 PUFA, †3.280.19 mL · min1 · g1).
Cardiac energy efficiency was correspondingly decreased
during reperfusion in REF and SAT hearts but not signifi-
cantly in n-3 PUFA hearts. (Control efficiency: REF,
2.930.34%; SAT, *1.280.07%; n-3 PUFA,
†5.170.77%. Reperfusion efficiency: REF, 1.940.27%;
SAT, *0.920.05%; n-3 PUFA, †4.780.36%). Reperfusion
release of lactate (REF, 36934; SAT, *42045; n-3 PUFA,
†15039 mol · min1 · g1) and creatine kinase (REF,
19.00.8; SAT, *24.30.8; n-3 PUFA, †5.20.7 IU · min1
· g1) were significantly greater than after ischemia at low
preload but lower in n-3 PUFA hearts than in REF or SAT
hearts.
Basal MVO2
Hearts arrested in diastole by 30 mmol/L KCl infusion after
reperfusion (n5 per diet) or time-matched control perfusion
(n5 per diet) had very low MVO2, representing noncontrac-
tile (basal) metabolism (Table). No significant effect of diet
or reperfusion was observed after KCl arrest.
Coronary Flow
Hydralazine increased coronary flow in REF and n-3 PUFA
hearts but not in SAT hearts and abolished the dietary
differences. (n10 per diet. Control: REF, 5110; SAT,
775; n-3 PUFA, 514 mL · min1 · g1. Hydralazine: REF,
6712; SAT, 7110; n-3 PUFA, 7410 mL · min1 · g1).
Intracellular Calcium Modulation
At a concentration that did not affect CO (data not shown) or
external work (Figure 6A), ruthenium red reduced MVO2 in
REF and SAT hearts to similar levels as those in n-3 PUFA
hearts (Figure 6B). Ryanodine had no effect on CO, external
work (Figure 6A), or MVO2 (Figure 6B) but totally abolished
ventricular fibrillation in reperfusion (Figure 6C). Ruthenium
red had no significant effect on reperfusion arrhythmias
(P0.05, 2).
Discussion
Dietary fish oil reduced MVO2 while sustaining cardiac
output and external work, revealing an increase in the
efficiency of oxygen use under conditions of constant heart
rate, preload, and afterload. When hearts were put under
stress, such as increased filling pressure or acute myocardial
ischemia and reperfusion, this low oxygen demand was
associated with enhanced hemodynamic function and reduced
production of markers of ischemic damage.
Changes in both coronary flow and oxygen extraction
contributed to the differences in MVO2 seen in these hearts.
Figure 5. Effects of dietary lipids on external work (A), MVO2 (B), and efficiency of cardiac oxygen use (C) during reperfusion (Rep) after
acute (15-minute) global low-flow ischemia in isolated working heart: REF (open bars), SAT (cross-hatched), and n-3 PUFA diet (filled
bars). Values are meanSD; n10 per group. *P0.05 vs REF, ANOVA; #P0.05 vs control, ANOVA.
Effects of Dietary Lipids on Working and Basal MVO2 After
Arrest With 30 mmol/L KCl (37°C), Under Control Conditions or
During Reperfusion After 15 Minutes of Acute Low-Flow
Global Ischemia
MVO2, mL  min1  g1 dry weight
REF (n-6 PUFA) SAT n-3 PUFA
Control
Working 3.240.25 5.180.31* 1.810.28*
Basal 0.570.18 0.680.19 0.360.13
Reperfusion
Working 3.920.26 5.920.33* 2.180.25*
Basal 0.690.21 0.770.22 0.450.19
Values are meanSD (n5 per group).
*P0.05; significantly different compared with n-6–rich REF (ANOVA with
Scheffe’s comparison).
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The low coronary flow in n-3 PUFA hearts contrasted to the
vasodilator and antihypertensive properties of fish oil6 and
reflected a low oxygen demand. This afforded the n-3 PUFA
hearts a high vasodilator reserve, which was revealed by both
high workloads and the vasodilator hydralazine. In contrast,
the high coronary flow in SAT hearts was not responsive to
hydralazine or high workload and represented maximal va-
sodilation as an adaptive response to increased metabolic
requirements, rather than any direct vascular effect. The high
MVO2 and high washout of lactate in SAT hearts under
control or high preload conditions and after ischemia further
support this supposition. These data highlight further poten-
tial adverse cardiovascular effects of dietary saturated fat that
are also independent of effects on atherosclerosis and
thrombosis.
In view of the low MVO2 and low lactate release in n-3
PUFA hearts, we tested the hypothesis that they would
exhibit reduced vulnerability to ischemic stress. Typical
responses of venous acidosis and myocardial K loss were
elicited by low-flow global ischemia. Together with the
increase in lactate and creatine kinase washout recorded when
coronary perfusion pressure and flow were restored in reper-
fusion, these indicators of acute ischemic stress were greatly
attenuated in the n-3 PUFA hearts at high or low workloads.
The n-3 PUFA hearts also had better postischemic recovery
of hemodynamic and metabolic function, supporting reports
of cardioprotective properties in ischemia-reperfusion.14,18–22
In reperfusion, disproportionately high MVO2, despite a
diminished work output, 23–25 indicates reduced efficiency of
oxygen use by the heart. This appears paradoxical, as it
contrasts to direct work-related energy requirements. The
postischemic efficiency decrease was least evident in n-3
PUFA hearts, and recovery of cardiac work was greater.
There was no paradoxical increase in MVO2 in SAT hearts
because of their already high demand, and this was reflected
in poor hemodynamic recovery.
These observations extend the range of effects on cardiac
function observed in vivo that are associated with dietary-
induced changes in myocardial fatty acid composition.16
Dietary n-3 PUFA reduced the susceptibility to arrhythmias
in the present study, as in other studies.10–15 The reduced loss
of K during ischemia may be indicative of effects on ion
channels or exchange mechanisms that lead to changes in K
conductance26 and altered arrhythmic potential.27 Alterna-
tively, the lower MVO2 in n-3 PUFA hearts suggested a
metabolic reserve, which may contribute to the reduced
arrhythmia vulnerability by ensuring energy for maintenance
of transmembrane potentials.
Underlying changes in mitochondrial metabolism may
contribute to the high oxygen energy utilization efficiency of
n-3 PUFA hearts. Reduced rates of mitochondrial respiration
are seen in hearts from fish oil–fed rats.28,30 Paradoxical
increases in MVO2 during reperfusion may in turn be driven
by increased energy requirements to regulate intracellular
Ca2, which is raised during ischemia.27–30 Spontaneous Ca2
release from sarcoplasmic reticulum and impaired contractil-
ity after ischemic injury29 suggest the ability of sarcoplasmic
reticulum to deal with elevated intracellular Ca2 may also be
impaired.
There is direct evidence of elevated intracellular (mito-
chondrial) Ca2 in hearts fed saturated fat or REF diets,
whereas n-3 PUFA are associated with less activation of
Ca2-dependent pyruvate dehydrogenase at rest and after
stimulation by catecholamines.30 Lower oxygen consumption
by mitochondria isolated from n-3 PUFA hearts, most notably
during uncoupled respiration, suggests that augmented n-3
PUFA content in inner mitochondrial membranes may min-
imize thermodynamic inefficiency because of high rates of
proton motive force and proton leak that may underlie futile
consumption of excess oxygen after ischemia-reperfusion.30
State III respiration may also be influenced by n-3 PUFA.21
The findings of the present study—in which excess MVO2
was abolished by ruthenium red (blocks mitochondrial
uniporter Ca2 uptake) but not by ryanodine (blocks sarco-
plasmic reticulum Ca2 release), although ryanodine but not
ruthenium red abolished postischemic cardiac arrhythmias—
promote the hypothesis that n-3 PUFA prevent intracellular
Ca2 overload.
The fatty acid composition of myocardial membrane phos-
pholipid is sensitive to the type of fatty acids consumed in the
diet.9–14,18–20,30–32 Although fish oils often contain mainly
EPA, the myocardium, including mitochondrial membrane,
accumulates DHA as the principal n-3 PUFA, even after
feeding purified EPA.13 We previously reported the effects of
the very diets used in the present study,10 demonstrating high
incorporation of DHA with fish oil feeding. Membrane fatty
Figure 6. Effects of dietary lipids, ruthenium red (3.4 mol/L), and ryanodine (1 nmol/L) on cardiac external work (A), MVO2 during con-
trol perfusion (B), and incidence of ventricular fibrillation (C) during reperfusion in isolated working heart: REF (open bars), SAT (cross-
hatched), and n-3 PUFA (filled bars). Values are meanSD; n10 per group. *P0.05 vs REF; #P0.05 vs control, ANOVA (external
work and MVO2) and 2 (ventricular fibrillation).
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acid modulation may modify a wide variety of intracellular
and membrane events, such as ion flux, respiratory electron
transport, carrier-mediated transport, membrane-bound en-
zyme activity, receptor function, intracellular lipid-based
second messengers, and eicosanoid synthesis.25,34 Thus,
membrane modification of phospholipid properties may im-
pact on many lipid-protein interactions, membrane protein
function, and membrane-dependent signaling and metabo-
lism. It is therefore not surprising that dietary lipid-induced
modulation of Ca2 handling30–33 via altered cardiac mem-
brane composition may drive both excessive oxygen use and
arrhythmia vulnerability.
Diet-induced augmentation of cardiac membrane n-3
PUFA improved ventricular function by reducing the oxygen
required to produce any given work output compared with
either saturated fat or n-6 PUFA. This was particularly
evident at high workloads and was not attributable to altered
vascular function. Increased n-3 PUFA incorporation made
the myocardium less susceptible to ischemic injury and aided
postischemic recovery. These findings provide further sup-
port for epidemiological and intervention studies that show
associations between n-3 PUFA intake and low incidence of
death from coronary heart disease, even after myocardial
infarction.1–5 The results suggest direct cardioprotective ef-
fects of fish oil, beyond the acknowledged antiatherogenic
and antithrombotic actions.
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